[
  {
    "ts": null,
    "headline": "Eli Lilly: Still Expensive As Earnings Near, But Not Worthy Of A Downgrade",
    "summary": "Financial writer cautious on Eli Lilly stock despite strong performance, citing high valuation and underperforming drugs.",
    "url": "https://finnhub.io/api/news?id=ca252f8d2f0175b19346cf4e77df62c7d3f891418ce1cd2aea88d914a31354d2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736579106,
      "headline": "Eli Lilly: Still Expensive As Earnings Near, But Not Worthy Of A Downgrade",
      "id": 132377273,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2188209231/image_2188209231.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Financial writer cautious on Eli Lilly stock despite strong performance, citing high valuation and underperforming drugs.",
      "url": "https://finnhub.io/api/news?id=ca252f8d2f0175b19346cf4e77df62c7d3f891418ce1cd2aea88d914a31354d2"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Could Serve As High-Yield Bond Alternative",
    "summary": "Johnson & Johnson remains a Buy for its stability and consistent dividends, despite short-term price fluctuations and modest growth expectations.",
    "url": "https://finnhub.io/api/news?id=eec953d3ebefe756ee954d02753d8b2f386dade2ea9ab287552280a1c40e3dcc",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736577419,
      "headline": "Johnson & Johnson Could Serve As High-Yield Bond Alternative",
      "id": 132377183,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2083966639/image_2083966639.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Johnson & Johnson remains a Buy for its stability and consistent dividends, despite short-term price fluctuations and modest growth expectations.",
      "url": "https://finnhub.io/api/news?id=eec953d3ebefe756ee954d02753d8b2f386dade2ea9ab287552280a1c40e3dcc"
    }
  }
]